In our study, the CT26 subcutaneous tumor was confirmed as a “cold” tumor with little CD8+ T cell infiltration, which may partly explain the limited anti-tumor efficacy of the monotherapy with TIGIT blockade in the previous studies [28, 29]. The gene discussed is CD8A; the disease is neoplasm.